Annual Grant Award Dollars

Investigator Title Sponsor ID Dates Amount
Lara Danziger-Isakov, MD-MPH A Multicenter Prospective Study of Human Adenovirus Infection and Disease in Pediatric Human Stem Cell Transplant Recipients National Institutes of Health (NIH)/Children's Hospital of Philadelphia HHSN272201600014C 8/22/18-12/31/21 $66,479
Lara Danziger-Isakov, MD-MPH A Phase II Multi-Center, Prospective, Randomized, Double Blind Study of Nitazoxanide in Acute and Chronic Norovirus in Hematpoietic Stem Cell and Organ Transplant Recipients National Institutes of Health (NIH)/Northwestern University Medical School HHSN272201600016C 9/1/21-8/31/22 $179,125
Steven Black, MD CISA Clinical Vaccine Safety Evaluation - Contributing C Ctr for Disease Control and Prevention 200-2012-53661 9/16/20-9/28/22 $211,625
David I Bernstein, MD Mouse and Guinea Pig Models for Cytomegalovirus and Herpes National Institutes of Health (NIH) HHSN27200003 11/1/21-10/31/22 $787,849
Tina L Cheng Child Health Research Career Development Award (K12) National Institutes of Health (NIH) K12HD028827 12/1/21-11/30/22 $459,000
Elizabeth Schlaudecker, MD CISA 02 Maternal Flublok Ctr for Disease Control and Prevention 200-2012-53661-0010 9/15/20-9/14/22 $179,997
Mary Allen Staat, MD Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza Immunity National Institutes of Health (NIH) U01AI144673 5/1/22-4/30/23 $4,442,677
Sing Sing Way, MD-PHD Progesterone induced immune modulation during pregnancy National Institutes of Health (NIH) R01AI145840 7/1/21-6/30/22 $756,664
Robert W Frenck, MD RTOP FY2020.A1B1C1D10123-Task A National Institutes of Health (NIH) HHSN272201300016I 7/12/21-7/11/22 $211,415
John J Erickson, MD-PHD Maternal microchimerism transfers cellular immunity to offspring National Institutes of Health (NIH) F32AI145184 7/1/21-6/30/22 $79,842
Paul W Spearman, MD Role of Vpu, Tetherin, and Siglec 1 National Institutes of Health (NIH) R01AI150475 9/1/21-8/31/23 $408,407
Robert W Frenck, MD Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required) National Institutes of Health (NIH) UM1AI148372 12/1/21-11/30/22 $2,708,294
Paul W Spearman, MD Leadership Group for the Infectious Diseases Clinical Research Consortium National Institutes of Health (NIH)/Emory University A601880 12/1/21-11/30/22 $62,337
Paul W Spearman, MD Viral and Cellular Determinants of HIV-1 Assembly - Resu National Institutes of Health (NIH) R01AI150486 2/1/22-1/31/23 $357,750
Koichi Araki DVM Translational Regulation of CD National Institutes of Health (NIH) 7R01AI139675 8/1/21-7/31/22 $454,637
Mary Allen Staat, MD PREVAIL COVID-19 Supplemental Ctr for Disease Control and Prevention U01IP001059 5/1/20-8/31/20 $1,545,487
Paul W Spearman, MD Role of Siglec-1 in HIV Interactions with Microglia and Astrocytes National Institutes of Health (NIH) R01DA051895 5/1/22-4/30/23 $495,301
Joseph Edward Qualls, PHD Lactate metabolism and host defense against Mycobacterium tuberulosis American Lung Association IA-696872 7/1/21-6/30/22 $75,000
Joseph Edward Qualls, PHD Preserving T cell / antigen presenting cell interactions via shared L-arginine National Institutes of Health (NIH) R21AI148612 9/1/21-8/31/22 $198,750
Mary Allen Staat, MD IMPRINT COVID-19 Supplement National Institutes of Health (NIH) 3U01AI144673-02S1 5/1/22-4/30/23 $816,161
Mary Allen Staat, MD Overcoming COVID-19 Vaccine Effectiveness Ctr for Disease Control and Prevention/Children's Hospital Boston 75D30120C07725 Subco 4/9/20-5/4/22 $59,946
Sing Sing Way, MD-PHD Covid Progesterone Supplement National Institutes of Health (NIH) 3R01AI145840-02S1 12/1/21-6/30/22 $538,121
Robert W Frenck, MD DMID 21-0002: Phase 1, Open-Label, Randomized Study of the Safety and Immunogenicity of a SARS-CoV-2 Variant Vaccine (mRNA-1273.351) in healthy adults National Institutes of Health (NIH) 3UM1AI148372-02S1 12/1/21-11/30/22 $1,629,888
Elizabeth Schlaudecker, MD CISA Pediatric COVID Ctr for Disease Control and Prevention 200-2012-53661 1/1/21-12/31/23 $697,191
Elizabeth Schlaudecker, MD CISA Adult COVID Ctr for Disease Control and Prevention 200-2012-53661 12/1/20-11/20/22 $743,179
Elizabeth Schlaudecker, MD CISA Maternal COVID Ctr for Disease Control and Prevention 200-2012-53661 12/1/20-11/30/23 $697,827
Monica Malone McNeal PATH Vaccine Solutions Bill & Melinda Gates Foundation/PATH Vaccine Solutions PATH_McNeal,M 7/1/21-3/31/23 $893,090
Andrew Cox, MD-PHD Improving vaccine efficacy by circumventing NK cell-mediated immune suppression National Institutes of Health (NIH)/Cornell University 215518-3 7/1/21-6/30/22 $119,880
Nina S Prasanphanich, MD-PHD Mechanisms of increased maternal susceptibility to E. coli and correlates of protection by pre-conceptual priming National Institutes of Health (NIH)/Cornell University 215518-8 7/1/21-6/30/22 $119,880
Mary Allen Staat, MD PICLFU Study National Institutes of Health (NIH)/Children's Hospital Boston GENFD0002024871 9/18/20-8/31/24 $40,273
Mary Allen Staat, MD US Enhanced Surveillance Network Ctr for Disease Control and Prevention 1 U01IP001155-01-00 9/1/21-8/31/22 $1,078,854
Paul W Spearman, MD Defining Antibody responses to influenza vaccines in infants and young children The John Hauck Foundation Hauck_Spearman 9/15/21-9/14/22 $100,000
Mary Allen Staat, MD US Enhanced Surveillance Network Ctr for Disease Control and Prevention 1 U01IP001155-01-00 9/1/21-8/31/22 $362,789
Monica Malone McNeal Environmental Enteric Dysfunction and Rotavirus vaccine responses in Zambian Bill & Melinda Gates Foundation/Centre for Infectious Disease Research i M148F1 INV-0317593 8/15/21-2/28/22 $20,000
Robert W Frenck, MD Blood Donation for Development Fondazione Toscana Life Sciences FondazioneToscana - 11/19/21-11/18/24 $4,438
Mark Murphy, DO Optimizing Voriconazole Therapy Using Model-Informed Precision Dosing Thrasher Research Fund Thrasher_Murphy 1/1/21-12/31/21 $5,412
Paul W Spearman, MD Nippert - COVID VLP L&L Nippert Charitable Foundation L and L Nippert Spea 12/1/21-11/30/22 $75,000
Paul W Spearman, MD Vaccinology Training Program National Institutes of Health (NIH) T32AI165396 2/9/22-1/31/23 $154,113
Lara Danziger-Isakov, MD-MPH Clinical Trials in Organ Transplantation National Institutes of Health (NIH)/Duke University A03-5348/1U01AI16309 8/13/21-5/31/22 $68,717
Total Annual Grant Award Dollars $21,905,395

Annual Industry Award Dollars

Investigator Industry Sponsor Amount
Robert W Frenck, MD Emergent BioSolutions $30,436
Robert W Frenck, MD Pfizer, Inc. $32,456
Paul W Spearman, MD CyanVac LLC $44,503
Lara Danziger-Isakov, MD-MPH Pfizer, Inc. $37,768
David I Bernstein, MD Gilead Sciences, Inc. $340,398
Mary Allen Staat, MD Cepheid $151,602
David I Bernstein, MD ModernaTX, Inc $98,678
Lara Danziger-Isakov, MD-MPH Merck & Company, Inc./Albert Einstein College of Medicine $16,609
Total Annual Industry Award Dollars $752,450